Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The pneumothorax treatment devices industry has experienced significant growth recently, driven by advances in medical technology and rising healthcare demands. As the need for effective lung collapse treatments increases worldwide, this market is set to expand further, supported by innovations and growing emergency care infrastructure. Below is a detailed overview of the market’s size, key growth drivers, segmentation, competitive landscape, and regional insights.
Market Size and Growth Outlook for Pneumothorax Treatment Devices
The pneumothorax treatment devices market has shown rapid expansion in recent years. It is projected to increase from $3.98 billion in 2025 to $4.39 billion in 2026, with a compound annual growth rate (CAGR) of 10.3%. This historical growth has been fueled by factors such as a rise in traumatic chest injuries, more frequent road accidents, expansion of hospital emergency facilities, wider adoption of chest tube procedures, and growth in critical care units. Looking ahead, the market is expected to continue its strong momentum, reaching $6.43 billion by 2030 at a CAGR of 10.0%. Key drivers during the forecast period include the development of portable emergency devices, advancements in thoracic vent systems, increasing ICU admissions, demand for rapid lung re-expansion, and the growth of emergency medical services. Emerging trends to watch include ultra-rapid lung decompression, portable pneumothorax management tools, minimally invasive chest drainage options, enhanced air leak control systems, and user-friendly bedside treatment kits.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20929&type=smp
Increasing Prevalence of Respiratory Illnesses Boosts Market Demand
One of the primary factors propelling the pneumothorax treatment devices market is the rising incidence of respiratory diseases. These conditions affect lung function and airflow, causing breathing difficulties. Their growth can be linked to environmental pollution, smoking habits, viral infections, and greater exposure to allergens. Pneumothorax devices play a critical role in managing lung collapse and restoring normal respiration in such cases. To illustrate, data released in September 2025 by the Australian Bureau of Statistics showed that influenza-related deaths climbed from 611 in 2023 to 806 in 2024, and further surged to 1,057 by August 2025—a 73% increase over the period. Similarly, fatalities due to respiratory syncytial virus (RSV) increased from 380 in 2023 to 468 in 2024, with 399 deaths recorded by August 2025. These upward trends in respiratory illnesses directly stimulate the demand for pneumothorax treatment devices.
Core Segments and Growth Areas in the Pneumothorax Treatment Devices Market
This market is divided into several important segments to better understand growth opportunities:
1) By Type: Ventilator Devices, Thoracic Vent Devices, and Other Types
2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, and other uses
3) By End-User: Hospitals, Ambulatory Surgical Centers, and other users
Access The Complete Pneumothorax Treatment Devices Market Report:
Further sub-classifications include:
– Ventilator Devices: Portable, Non-Invasive, and Invasive Ventilators
– Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, and One-Way Chest Valve Systems
– Other Types: Needle Aspiration Devices, Pleural Catheters, and Oxygen Therapy Devices
Innovative Technologies Driving the Next Wave of Market Development
Leading companies in the pneumothorax treatment devices sector are prioritizing the development of advanced technologies to maintain competitiveness. Among these innovations are enhanced chest X-ray solutions, which offer improved imaging for diagnosing lung-related conditions. For example, in September 2023, Qure.ai, a US-based health technology firm, received FDA 510(k) clearance for its chest X-ray tool, qXR-PTX-PE. This AI-powered software aids in the rapid identification of pneumothorax and pleural effusion, supporting faster decision-making in critical care settings like ICUs and emergency rooms. By analyzing chest radiographs quickly and accurately, the solution improves patient triage and care efficiency where timely intervention is crucial.
Top Competitors and Market Dynamics in Pneumothorax Treatment Devices
Several prominent companies dominate the pneumothorax treatment devices landscape, including Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., and Selio Medical Inc. These firms focus on innovation, regulatory approvals, and expanding product portfolios to sustain and enhance their market presence.
North America Holds the Largest Share in Pneumothorax Treatment Devices Market
In 2025, North America accounted for the largest share of the pneumothorax treatment devices market. The report covers multiple regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, each showing varied growth trajectories. While North America leads currently, some regions like Asia-Pacific are expected to witness significant growth rates in the coming years as healthcare infrastructure develops and awareness increases.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
